A case-comparison study of pregnant women with mitochondrial disease - what to expect?


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
Oct 2019
Historique:
accepted: 19 02 2019
pubmed: 26 2 2019
medline: 24 9 2019
entrez: 26 2 2019
Statut: ppublish

Résumé

Mitochondrial disease is a disorder of energy metabolism that affects 1 in 4300 adults in the UK. Pregnancy is associated with physiological demands that have implications for energy metabolism. We were interested to know how pregnancy was affected in women with mitochondrial disease, particularly those with the most common pathogenic mutation m.3243A>G. Retrospective case-comparison study. Sixty-seven women with genetically confirmed mitochondrial disease from the UK Mitochondrial Diseases Cohort and 69 unaffected women participated. Participants answered questionnaires regarding each of their pregnancies. Patients were divided into two groups according to genetic mutation, with those harbouring m.3243A>G comprising a single group. Pregnancy-related complications, mode of delivery, gestational age and birthweight of newborns. Of 139 live births in the comparison group, 62 were in the m.3243A>G group and 87 were in the 'all other mutations' group. Pregnancies of women with the m.3243A>G mutation had significantly more gestational diabetes (odds ratio [OR] = 8.2, 95% CI 1.3-50.1), breathing difficulties (OR = 7.8, 95% CI 1.0-59.1) and hypertension (OR = 8.2, 95% CI 3.1-21.5) than the comparison group. Only half of the pregnancies in the m.3243A>G group had normal vaginal delivery, with emergency caesarean section accounting for 24.2% of deliveries. Babies were born significantly earlier to mothers harbouring m.3243A>G with 53.3% of them preterm (<37 weeks). These babies were also more likely to require resuscitation and admission. Women who carried the m.3243A>G mutation appeared to be at higher risk of complications during pregnancies, caesarean section and preterm delivery than the unaffected women or those with other forms of mitochondrial disease. Pregnant women with mitochondrial disease - m.3243A>G mutation - are at greatly increased risk of complications and preterm delivery.

Identifiants

pubmed: 30801962
doi: 10.1111/1471-0528.15667
pmc: PMC6767368
doi:

Substances chimiques

DNA, Mitochondrial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1380-1389

Subventions

Organisme : Medical Research Council
ID : MR/K000608/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206001/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0800674
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N020820/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L016354/1
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists.

Références

Nature. 1990 Dec 13;348(6302):651-3
pubmed: 2102678
Lancet Neurol. 2010 Aug;9(8):829-40
pubmed: 20650404
N Engl J Med. 2015 Feb 26;372(9):885-887
pubmed: 25629662
J Neurol. 2014 Mar;261(3):504-10
pubmed: 24375076
Obstet Med. 2011 Sep;4(3):90-4
pubmed: 27579099
Mitochondrion. 2015 Nov;25:98-103
pubmed: 26455484
Health Technol Assess. 2016 Nov;20(86):1-348
pubmed: 27917777
Ann Neurol. 2015 May;77(5):753-9
pubmed: 25652200
Mitochondrion. 2007 May;7(3):230-3
pubmed: 17300999
Hum Reprod Update. 2017 Sep 1;23(5):501-519
pubmed: 28651360
BMC Pregnancy Childbirth. 2014 Jul 05;14:221
pubmed: 24996683
Arch Dis Child. 2000 Mar;82(3):202-3
pubmed: 10685920
Ultrasound Obstet Gynecol. 1995 Sep;6(3):168-74
pubmed: 8521065
Intern Med. 1998 Sep;37(9):780-3
pubmed: 9804089
BJOG. 2019 Oct;126(11):1380-1389
pubmed: 30801962
Am J Hum Genet. 2008 Aug;83(2):254-60
pubmed: 18674747
BMJ. 1998 Feb 21;316(7131):566-7
pubmed: 9518893
PLoS One. 2013 May 09;8(5):e64351
pubmed: 23671712
Hypertension. 2018 Sep;72(3):703-711
pubmed: 30012871
Diabetologia. 2007 Oct;50(10):2085-9
pubmed: 17653689
BMJ Open. 2011 May 24;1(1):e000101
pubmed: 22021762
J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):936-8
pubmed: 23355809

Auteurs

C L Feeney (CL)

NHS Specialised Service for Rare Mitochondrial Disorders of Adults and Children, Newcastle-upon-Tyne, UK.
Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK.

A Z Lim (AZ)

NHS Specialised Service for Rare Mitochondrial Disorders of Adults and Children, Newcastle-upon-Tyne, UK.
Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK.

E Fagan (E)

Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK.

A Blain (A)

Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK.

A Bright (A)

NHS Specialised Service for Rare Mitochondrial Disorders of Adults and Children, Newcastle-upon-Tyne, UK.
Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK.

J Maddison (J)

Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK.

H Devine (H)

MRC Centre for Neuromuscular Diseases, Institute of Neurology, University College London, London, UK.

J Stewart (J)

Newcastle Fertility Centre, International Centre for Life, Newcastle, UK.

R W Taylor (RW)

NHS Specialised Service for Rare Mitochondrial Disorders of Adults and Children, Newcastle-upon-Tyne, UK.
Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK.

G S Gorman (GS)

NHS Specialised Service for Rare Mitochondrial Disorders of Adults and Children, Newcastle-upon-Tyne, UK.
Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK.

D M Turnbull (DM)

NHS Specialised Service for Rare Mitochondrial Disorders of Adults and Children, Newcastle-upon-Tyne, UK.
Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK.

V Nesbitt (V)

Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK.

R McFarland (R)

NHS Specialised Service for Rare Mitochondrial Disorders of Adults and Children, Newcastle-upon-Tyne, UK.
Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH